WCLC 2022 – Federico Cappuzzo

Federico Cappuzzo discusses the effectiveness and limitations of minimal residual disease (MRD) assessment in the detection of patients with early-stage lung cancer at low risk of relapse and highlights which clinical investigations regarding the clinical impact of MRD assessments in solid tumors are ongoing and what we can expect from them in the future.

Here is the full WCLC 2022 report.